OpenVSafe by OpenVAERS
Search V-safe

3MZ-19185-19173

4 vaccinations 6 coded responses 36 check-ins 6 free-text entries 5 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
352 / AL
Registered
2021-03-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2419464 (opens in a new window) high 10 / 11 — 4 of 9 VAERS symptoms same dose (4) AL matches 2022-04-24 / 2022-07-15 / 2022-08-24
received the same day as the last call
 case 881562

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-03-23
    Registered in v-safe
  2. 2021-03-23
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-23
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-30
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  10. 2021-04-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-13
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-13
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-04-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Chills
    Adult check-in
  15. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  16. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site
    Adult check-in
  17. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site
    Adult check-in
  18. 2021-04-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site
    Adult check-in
  19. 2021-04-20
    Health check-in — day 7, dose 2
    Feeling: Poor · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  20. 2021-04-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-04
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-05-11
    Survey response — day 28, dose 2
    MedDRA: Fatigue, Headache, Myalgia, Nausea, Syncope, Thrombosis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Muscle aches, I developed a new blood clot in my leg, headaches, nausea, fatigue, and fainting spells.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-25
    Survey response — day 42, dose 2
    MedDRA: Emergency care, Fluid retention, Hypoaesthesia, Peripheral swelling — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: My legs started swelling last week and have not stopped swelling for about a week. On Sunday I started loosing the feeling in my toes and feet and went to the E.R. - they said its because of all the fluid. Now Im double in size that I was on Su
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-25
    Report sent to call center — day 42, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-07-13
    Survey response — 3 months, dose 2
    MedDRA: Hyperglycaemia — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Hyperglycemia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-07-13
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-07-15
  29. 2021-10-13
    Survey response — 6 months, dose 2
    MedDRA: Mental disorder, Migraine, Pre-existing disease, Type 1 diabetes mellitus — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Diabetes changed from type 2 to type 1 Migraines Psychological breakdown
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-13
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  31. 2021-10-15
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  32. 2021-12-15
    Dose 3 — Pfizer-BioNTech
  33. 2022-04-13
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in
  34. 2022-04-24
    Dose 4 — Pfizer-BioNTech
  35. 2022-04-24
    Health check-in — day 0, dose 4
    Feeling: Fair · None
    Adult check-in
  36. 2022-04-25
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    Adult check-in
  37. 2022-04-26
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  38. 2022-04-27
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  39. 2022-04-28
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  40. 2022-04-30
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  41. 2022-05-01
    Health check-in — day 7, dose 4
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  42. 2022-05-24
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  43. 2022-05-29
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  44. 2022-06-05
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  45. 2022-07-24
    Survey response — 3 months, dose 4
    MedDRA: Sinusitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Sinus infection
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-07-24
    Report sent to call center — 3 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  47. 2022-07-25
  48. 2022-07-25
  49. 2022-07-25
  50. 2022-07-25
  51. 2022-08-24
    Call successful
    Completed over the phone
  52. 2022-10-23
    Survey response — 6 months, dose 4
    MedDRA: Bronchitis, COVID-19 — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Severe Bronchitis associated with my COVID-19 infection.
    MedDRA releases: 2024-11 · check-in free text available
  53. 2022-10-23
    Report sent to call center — 6 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  54. 2022-10-25

Vaccinations

DoseDateManufacturerCo-administered
12021-03-23Pfizer-BioNTech
22021-04-13Pfizer-BioNTech
32021-12-15Pfizer-BioNTech No
42022-04-24Pfizer-BioNTech No

Call center

5 call center cases

4 successful · 1 unsuccessful

VAERS report filed, before or during a call: 1

2 waits over 3 months for a first call

See the call center timeline

Free text

Release 8 — day 28, dose 2

2021-05-11

Symptoms: Muscle aches, I developed a new blood clot in my leg, headaches, nausea, fatigue, and fainting spells.

Release 8 — day 42, dose 2

2021-05-25

Symptoms: My legs started swelling last week and have not stopped swelling for about a week. On Sunday I started loosing the feeling in my toes and feet and went to the E.R. - they said its because of all the fluid. Now Im double in size that I was on Su

Release 9 — 3 months, dose 2

2021-07-13

Symptoms: Hyperglycemia

Release 10 — 6 months, dose 2

2021-10-13

Symptoms: Diabetes changed from type 2 to type 1 Migraines Psychological breakdown

Release 12 — 3 months, dose 4

2022-07-24

Symptoms: Sinus infection

Release 12 — 6 months, dose 4

2022-10-23

Symptoms: Severe Bronchitis associated with my COVID-19 infection.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBronchitis · · ✓
SDCOVID-19 · · ✓
SDEmergency care ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDFluid retention ✓ · ✓
SDHeadache ✓ ✓ ✓
SDHyperglycaemia ✓ ✓ ✓
SDHypoaesthesia ✓ ✓ ✓
SDMental disorder · · ✓
SDMigraine · · ✓
SDMyalgia ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDPeripheral swelling ✓ ✓ ✓
SDPre-existing disease · · ✓
SDSinusitis · · ✓
SDSyncope ✓ ✓ ✓
SDThrombosis ✓ ✓ ✓
SDType 1 diabetes mellitus · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…